Kinnate Biopharma Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Kinnate Biopharma Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q4 2023.
  • Kinnate Biopharma Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $2.49M, a 26.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $2.49M -$889K -26.3% Dec 31, 2023 10-K 2024-03-28
Q3 2023 $2.66M -$921K -25.7% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $2.96M -$823K -21.8% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $3.17M -$809K -20.3% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $3.38M +$3.38M Dec 31, 2022 10-K 2024-03-28
Q3 2022 $3.58M Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $3.78M Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $3.98M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.